SC 13G

Company

Ultragenyx Pharmaceutical Inc.

Filed

January 10, 2018

Accession Number

0001562230-18-000003

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →